Literature DB >> 26094844

Pharmacotherapy for alcohol addiction in a patient with alcoholic cirrhosis and massive upper gastrointestinal bleed: A case study.

Samantha Young1, Evan Wood1,2,3, Keith Ahamad2,3,4.   

Abstract

Alcohol use causes a substantial burden of morbidity and mortality worldwide. The pharmacologic treatment of alcohol dependence has been increasingly studied and proven to improve outcomes in individuals with alcohol use disorder. However, the treatment of alcohol use disorder is often challenging in the context of patients with hepatic impairment as many medications to treat alcohol use disorder are hepatically metabolised or may cause liver toxicity in some instances. We present a case history of an individual with significant medical complications from alcohol use disorder and explore the dilemma faced in prescribing pharmacologic treatment of alcohol use disorder in patients with significant liver dysfunction.
© 2015 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Keywords:  addiction treatment; alcohol-related disorder; alcoholism; drug therapy; liver cirrhosis

Mesh:

Year:  2015        PMID: 26094844      PMCID: PMC5266525          DOI: 10.1111/dar.12289

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  13 in total

Review 1.  Defining the role of baclofen for the treatment of alcohol dependence: a systematic review of the evidence.

Authors:  Andrew J Muzyk; Sarah K Rivelli; Jane P Gagliardi
Journal:  CNS Drugs       Date:  2012-01-01       Impact factor: 5.749

2.  The quality of health care delivered to adults in the United States.

Authors:  Elizabeth A McGlynn; Steven M Asch; John Adams; Joan Keesey; Jennifer Hicks; Alison DeCristofaro; Eve A Kerr
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

Review 3.  Pharmacotherapy for alcoholic patients with alcoholic liver disease.

Authors:  Cynthia L Vuittonet; Michael Halse; Lorenzo Leggio; Samuel B Fricchione; Michael Brickley; Carolina L Haass-Koffler; Tonya Tavares; Robert M Swift; George A Kenna
Journal:  Am J Health Syst Pharm       Date:  2014-08-01       Impact factor: 2.637

4.  Study of hepatotoxicity of naltrexone in the treatment of alcoholism.

Authors:  Mao-Hsiung Yen; Huei-Chen Ko; Fu-In Tang; Ru-Band Lu; Jau-Shyong Hong
Journal:  Alcohol       Date:  2006-02       Impact factor: 2.405

5.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Authors:  Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

6.  Gabapentin treatment for alcohol dependence: a randomized clinical trial.

Authors:  Barbara J Mason; Susan Quello; Vivian Goodell; Farhad Shadan; Mark Kyle; Adnan Begovic
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

7.  Disulfiram-induced hepatitis. Report of four cases and review of the literature.

Authors:  X Forns; J Caballería; M Bruguera; J M Salmerón; A Vilella; A Mas; A Parés; J Rodés
Journal:  J Hepatol       Date:  1994-11       Impact factor: 25.083

8.  Topiramate for treating alcohol dependence: a randomized controlled trial.

Authors:  Bankole A Johnson; Norman Rosenthal; Julie A Capece; Frank Wiegand; Lian Mao; Karen Beyers; Amy McKay; Nassima Ait-Daoud; Raymond F Anton; Domenic A Ciraulo; Henry R Kranzler; Karl Mann; Stephanie S O'Malley; Robert M Swift
Journal:  JAMA       Date:  2007-10-10       Impact factor: 56.272

9.  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.

Authors:  Giovanni Addolorato; Lorenzo Leggio; Anna Ferrulli; Silvia Cardone; Luisa Vonghia; Antonio Mirijello; Ludovico Abenavoli; Cristina D'Angelo; Fabio Caputo; Antonella Zambon; Paul S Haber; Giovanni Gasbarrini
Journal:  Lancet       Date:  2007-12-08       Impact factor: 79.321

10.  Effect on cessation counseling of documenting smoking status as a routine vital sign: an ACORN study.

Authors:  Stephen F Rothemich; Steven H Woolf; Robert E Johnson; Amy E Burgett; Sharon K Flores; David W Marsland; Jasjit S Ahluwalia
Journal:  Ann Fam Med       Date:  2008 Jan-Feb       Impact factor: 5.166

View more
  1 in total

Review 1.  New approaches for fibrosis regression in alcoholic cirrhosis.

Authors:  Wajahat Mehal; Uyen To
Journal:  Hepatol Int       Date:  2016-07-26       Impact factor: 6.047

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.